SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Pastimes : Georgia Bard's Corner -- Ignore unavailable to you. Want to Upgrade?


To: Ga Bard who wrote (4489)7/29/1998 12:00:00 PM
From: Brett Fleischman  Read Replies (2) | Respond to of 9440
 
Isn't that funny, as soon as Dog posts an attack on CCGI, big sells came through...hmmmmm, maybe the Doggie's new way of doing business, short everyone elses picks to make his doo doo look good.

Brett



To: Ga Bard who wrote (4489)7/29/1998 12:16:00 PM
From: bob sims  Read Replies (1) | Respond to of 9440
 
BTW Ga,

DYNT that I told you about last month has gone from $1.00 to $5.00 with plenty of more room to grow. This just came out.

Bob

**********************************************************************

Dynatronics Projects 170 Percent Sales Growth as New 'Synergie' Products Roll Out

SALT LAKE CITY, July 29 /PRNewswire/ -- Dynatronics Corporation (Nasdaq: DYNT - news) today announced that it has begun shipments of
its new Synergie AMS(TM) (Aesthetic Massage System) device. Sales projections for the device are expected to trigger a 170 percent hike in
annual corporate sales.

The Synergie AMS device is part of the revolutionary Synergie Lifestyle System(TM) recently introduced by Dynatronics. Combining subdermal
tissue massage provided by the Synergie AMS treatment device with proper nutrition and exercise, the Synergie Lifestyle System helps women
attack well-known ''problem areas'' around thighs, hips, and buttocks where heredity, inactive lifestyle, and poor diet often result in an
undesirable appearance of the skin.

''We're extremely pleased with the demand for the new Synergie product line,'' stated Dynatronics' President, Kelvyn H. Cullimore, Jr. ''When
the product line was announced last month, the response was overwhelming and continues to exceed our highest expectations. Based on initial
Synergie AMS orders, we're projecting that sales for the fiscal year ending June 30, 1999, should increase by 170 percent to approximately
$30 million. With that increase, earnings for the fiscal year are projected to be in the range of $.40 per share.

''Manufacturing enough product to meet the demand remains our biggest challenge,'' added Cullimore. ''However, we believe that we can clear
the backlog of orders within four months. Even with that challenge, we're confident that we'll be able to meet the sales projections of $8 million,
and boost projected earnings to $.08 to $.12 per share for the current quarter.''

According to Larry K. Beardall, executive vice-president of marketing and sales, ''The excitement over the benefits provided by the Synergie
Lifestyle System has been clearly demonstrated by the receipt of more than 4,000 sales leads generated through our initial marketing efforts.
Dynatronics has never experienced this level of interest in a new product at any time in its 19-year history.

''In addition to unprecedented increases in sales and profits, the new Synergie product line provides Dynatronics with two essential ingredients
for continued long-term growth: new products and new markets,'' continued Beardall. ''Along with the Synergie AMS unit, we are also
introducing four complementary products, including additional capital equipment and consumable products. More importantly, we are expanding
into several lucrative new markets such as plastic surgery, dermatology, and other related cosmetic and aesthetic markets. We have, already
shown dramatic sales growth within our core business over the past two years. With Synergie, we're now in a position to continue this
extraordinary growth for many years to come.''

Dynatronics is a leading domestic manufacturer and marketer of advanced technology medical devices, orthopedic soft goods and supplies,
nutritional supplements, treatment tables, and rehabilitation equipment for the physical therapy, sports medicine, chiropractic, podiatry, plastic
surgery, dermatology, and other related medical, cosmetic, and aesthetic markets.

(The statements regarding the Company's expectations for growth in sales and profitability in future periods are forward-looking and actual
results may vary. Sales of the Company's products are subject to a number of risks and uncertainties, including, but not limited to changes in the
regulatory environment, the ability of the Company to react favorably to changing market conditions and growth in the physical medicine industry
and general economy; competitive factors, such as increased competition from new or established competitors; market acceptance of new
products; availability of third party component parts and products at reasonable prices; inventory risks due to shifts in market demand and/or
price erosion of purchased components; success of the Company in meeting actual demand for the products; changes in product mix; and the
risk factors listed from time to time in the Company's SEC reports, including, but not limited to the report on Form 10-QSB for the quarter ended
March 31, 1998 and 10-KSB for the year ended June 30, 1997.)

SOURCE: Dynatronics Corporation